Nabil Saba

Nabil Saba at Emory University's Winship Cancer Institute studies the prevention and treatment of head and neck cancers with particular attention to HPV vaccination impact on oropharyngeal cancer incidence. His research addresses chemoprevention strategies and tobacco cessation interventions to reduce HNSCC burden. He has contributed to clinical trials for high-risk oral lesions and early-stage oropharyngeal cancer. His public health work complements his clinical research on reducing HNSCC incidence through vaccination and risk modification.